Lineage Cell Therapeutics Inc. (LCTX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Broadwood Capital

Neal C. Bradsher

41,666,255 $61,666,057 +20% 4.63%
2.
Logos Capital

Arsani William

6,250,000 $9,250,000 0.74%
3. 1,366,308 $2,022,136 0.46%
4. 221,220 $327,406 -63% 0%
5.
D E Shaw

D. E. Shaw

186,627 $276,208 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.05 10,000 154,842 2024-05-24 Filing
$1.04 96,155 Director 158,801 2024-02-08 Filing
$0.00 0 Large Shareholder, Director 41,666,255 2024-02-06 Filing
$1.04 6,730,770 Large Shareholder, Director 41,666,255 2024-02-06 Filing
$1.09 10,000 Director 10,000 2023-12-29 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.44 28,445 Officer 0 2021-12-29 Filing
$2.49 9,250 Officer 28,445 2021-12-29 Filing
$2.45 501,588 Officer 28,445 2021-12-28 Filing
$2.93 19,142 Director 15,578 2021-06-29 Filing
$2.97 4,720 Director 87,500 2021-06-29 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 8,531,498 $9,299,332 0%
2. 8,384,687 $9,139,309 0%
3. 4,969,675 $5,416,946 1.9%
4. 2,935,811 $3,200,483 0%
5. 2,131,621 $2,323,467 2.93%
News See All